TMCnet

Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Tre…

Ciobanu, A.C., Caseiro, D.M., Niu, R. et al. Negative allosteric modulation of mGlu7 disrupts fear memory reconsolidation and ...

Addex Therapeutics: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder ...

Data published in Molecular Psychiatry Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, February 3, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage ...
Drug Target Review

Targeting mGlu7 could lead to new anxiety and PTSD treatments

Explore innovative anxiety and PTSD treatments with Addex Therapeutics' groundbreaking research on mGlu7 modulators.
Medical Xpress

Pharmacologic Actions: News and Research on Mitosis Modulators

The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering agents, such as radiation and chemotherapy, during cancer treatment. For example, many patients with ...
Frontiers

Beyond Traditional Pharmacokinetics: The Expanding Influence of Microbiota, Bile Acids, and Other Modulators on Drug Metabolism and Transport

Classically, the study of pharmacokinetics (PK) has centered on hepatic metabolism and renal excretion as the primary ...
Frontiers

Harnessing Molecular Biophysics and AI for Cellular Disease Mechanisms and Drug Discovery

Recent developments in molecular biophysics and AI provide a path to connect biomolecular structure and dynamics with ...